Vazalore - A New Aspirin Formulation

Date: May 2, 2022
Issue #: 
1649Summary: 
The FDA has approved an over-the-counter (OTC)
liquid-filled capsule formulation of aspirin (Vazalore–
PLx Pharma). The manufacturer has been heavily
promotingVazalore with claims of fast, predictable
absorption and antiplatelet activity and improved
gastrointestinal safety compared to existing OTC
aspirin formulations.

Source: The Medical Letter - April 5, 2022 Category: Drugs & Pharmacology Authors: admin Source Type: research